Processing

Please wait...

Settings

Settings

Goto Application

1. MYPI 2012002889 - FUSED HETEROAROMATIC PYRROLIDINONES AS SYK INHIBITORS

Office
Malaysia
Application Number PI 2012002889
Application Date 17.12.2010
Publication Number PI 2012002889
Publication Date 30.03.2017
Publication Kind A
IPC
C07D 487/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
487Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
C07D 471/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
A61K 31/437
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
437the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
Applicants TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventors JONES, BENJAMIN
FEHER, VICTORIA
DONG, QING
TAKAHASHI, MASASHI
SMITH, CHRISTOPHER
NIE, ZHE
LAM, BETTY
ARIKAWA, YASUYOSHI
Agents KI WAN SIA*
Priority Data 61/289,969 23.12.2009 US
61/386,964 27.09.2010 US
Title
(EN) FUSED HETEROAROMATIC PYRROLIDINONES AS SYK INHIBITORS
Abstract
(EN) DISCLOSED ARE COMPOUNDS OF FORMULA1, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, WHEREIN G, L1, L2, R1, R2, R3, AND R4 ARE DEFINED IN THE SPECIFICATION. THIS DISCLOSURE ALSO RELATES TO MATERIALS AND METHODS FOR PREPARING COMPOUNDS OF FORMULA 1, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE FOR TREATING DISORDERS, DISEASES, AND CONDITIONS INVOLVING THE IMMUNE SYSTEM AND INFLAMMATION, INCLUDING RHEUMATOID ARTHRITIS, HEMATOLOGICAL MALIGNANCIES, EPITHELIAL CANCERS (I.E., CARCINOMAS), AND OTHER DISORDERS, DISEASES, AND CONDITIONS FOR WHICH INHIBITION OF SYK IS INDICATED.
Related patent documents
VNVN1201202064This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
KEKEP2012001594This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
MXMX/a/2012/007402This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
GE12794/1This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
GE12794This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
CO12121953This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
CRCR2012-000392This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
UAa201207806This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.